You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response

 

Online download statistics by month:

Online download statistics by month: February 2022 to August 2025

AbstractFullPdf
Feb 2022460468141
Mar 2022788801271
Apr 2022332342119
May 202224124382
Jun 202220420975
Jul 202219820457
Aug 202220020456
Sep 202218619267
Oct 202226227172
Nov 202220120172
Dec 202218818972
Jan 202314614661
Feb 202316917065
Mar 202316817074
Apr 202312912962
May 202317017272
Jun 202311411737
Jul 202313213356
Aug 2023929269
Sep 202317317466
Oct 202324224651
Nov 202333233256
Dec 202319119248
Jan 2024143145100
Feb 202413413480
Mar 2024149149217
Apr 202415115275
May 202417718080
Jun 202414014370
Jul 202414914860
Aug 202410210475
Sep 202412913043
Oct 202414114450
Nov 202416316472
Dec 202415315661
Jan 2025157158101
Feb 202518818877
Mar 202510210262
Apr 202514715170
May 202517317795
Jun 202510710855
Jul 2025221
Aug 2025110
Total792680333245